Barbara Dalton - Jun 2, 2022 Form 4 Insider Report for IMARA Inc. (ELVN)

Role
Director
Signature
/s/ Michael P. Gray, Attorney-in-Fact
Stock symbol
ELVN
Transactions as of
Jun 2, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 08:20 PM
Previous filing
Jul 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ELVN Common Stock 1.56M Jun 2, 2022 By entities affiliated with Pfizer Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELVN Stock Options (Right to Buy) Award $0 +8.5K $0.00 8.5K Jun 2, 2022 Common Stock 8.5K $1.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is Managing General Partner, Pfizer Ventures (US) LLC. The reporting person disclaims beneficial ownership of the shares owned by the entities affiliated with Pfizer Ventures (US) LLC except to the extent of her pecuniary interest therein.
F2 The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant.